Manulife (Manufacturers Life Insurance)
NYMX

Manulife (Manufacturers Life Insurance)’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,204
Closed -$62K – 3041
2020
Q3 		$62K Hold
25,204
– – ﹤0.01% 2883
2020
Q2 		$89K Buy
+25,204
New +$79.7K ﹤0.01% 2782
2018
Q2 		– Sell
-7,212
Closed -$31K – 4408
2018
Q1 		$31K Buy
+7,212
New +$25K ﹤0.01% 3661

Other funds holding NYMX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NYMX Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2020, closing a stake of 25,204 shares — an estimated $62K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NYMX in Q1 2018 and held it in 3 quarters. The position peaked at $89K in Q2 2020. 58 funds tracked by Wall St. Rank hold NYMX as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Nymox Pharmaceutical Corp position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 25,204 Nymox Pharmaceutical Corp shares in Q4 2020, an estimated $62K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Nymox Pharmaceutical Corp in Q1 2018 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Nymox Pharmaceutical Corp position peaked at $89K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.